When companies prepare for their next phase of growth, they don’t just expand markets, they strengthen their financial spine.

Intas Pharmaceuticals has announced the appointment of Saurabh Singhal as Deputy General Manager – Finance & Accounts. On the surface, it is a leadership update. In reality, it is a strategic move.

With over 14 years of experience across pharmaceuticals, FMCG, and automotive sectors, Saurabh brings a depth of understanding in financial planning, large-scale P&L oversight, strategic budgeting, forecasting, and automation-led transformation. His journey reflects more than technical expertise, it reflects operational maturity.

In a pharmaceutical business operating across global markets, financial leadership is not just about closing books. It is about enabling expansion, protecting margins, navigating compliance, and building scalable systems. Strong FP&A today is not a support function; it is a strategic lever.

This appointment signals intent; Intent to strengthen internal controls, Intent to align numbers with ambition, Intent to support growth with disciplined financial architecture.

As Intas continues to scale its global footprint, the role of finance becomes central to decision-making speed and accuracy. Leaders like Saurabh are not brought in merely to manage processes, they are brought in to build clarity in complexity.

Every growth story has a financial backbone. This is one of those next steps that strengthens it. Because in business, strategy may define direction, but finance sustains momentum.

For more such leadership movements and business insights, follow Gujpreneur